IE
EWTX icon

Israel Englander’s Edgewise Therapeutics EWTX Stock Holding History

Israel Englander’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-342,867
Closed -$10.8M – 6016
2026
Q1 		$10.8M Buy
342,867
+216,431
+171% +$6.24M ﹤0.01% 2100
2025
Q4 		$3.14M Sell
126,436
-598,989
-83% -$12M ﹤0.01% 3504
2025
Q3 		$11.8M Sell
725,425
-196,540
-21% -$2.79M 0.01% 2216
2025
Q2 		$12.1M Buy
921,965
+306,847
+50% +$4.42M 0.01% 2064
2025
Q1 		$13.5M Sell
615,118
-273,850
-31% -$7.18M 0.01% 1891
2024
Q4 		$23.7M Sell
888,968
-98,062
-10% -$3.12M 0.01% 1373
2024
Q3 		$26.3M Sell
987,030
-158,476
-14% -$3.15M 0.01% 1301
2024
Q2 		$20.6M Buy
1,145,506
+613,251
+115% +$10.7M 0.01% 1476
2024
Q1 		$9.71M Buy
532,255
+400,900
+305% +$6.37M ﹤0.01% 2216
2023
Q4 		$1.44M Buy
131,355
+95,462
+266% +$670K ﹤0.01% 3867
2023
Q3 		$206K Buy
+35,893
New +$244K ﹤0.01% 5106
2023
Q1 		– Sell
-42,208
Closed -$377K – 6493
2022
Q4 		$377K Sell
42,208
-116,286
-73% -$1.09M ﹤0.01% 4940
2022
Q3 		$1.56M Buy
158,494
+91,188
+135% +$921K ﹤0.01% 3974
2022
Q2 		$536K Buy
67,306
+6,314
+10% +$47.7K ﹤0.01% 4899
2022
Q1 		$592K Buy
+60,992
New +$785K ﹤0.01% 4995
2021
Q2 		– Sell
-60,077
Closed -$1.95M – 6665
2021
Q1 		$1.95M Buy
+60,077
New +$1.95M ﹤0.01% 3566

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's EWTX Position: Q2 2026 in Review

Israel Englander sold out of Edgewise Therapeutics (EWTX) in Q2 2026, closing a stake of 342,867 shares — an estimated $10.8M sold.

Israel Englander first reported a position in EWTX in Q1 2021 and held it in 16 quarters. The position peaked at $26.3M in Q3 2024. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Israel Englander reported no remaining Edgewise Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 342,867 Edgewise Therapeutics shares in Q2 2026, an estimated $10.8M.
  • Israel Englander first reported a position in Edgewise Therapeutics in Q1 2021 and held it in 16 quarters.
  • Israel Englander's Edgewise Therapeutics position peaked at $26.3M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.